News Room

At the height of the COVID-19 pandemic, supply chains became mainstream news when the Suez Canal was blocked by the Ever Given, and ports were clogged with countless vessels waiting to dock, resulting in the idling of 10% of the world’s container capacity. While most disruptions have dissipated, continued challenges led to the White House giving supply chains another bump in the news cycle with its inaugural meeting of the Council on Supply Chain Resilience.

From cancer care to communications, here’s where AI moved the needle in health care

As the FDA looks at whether a recent case of lead contamination in applesauce was economically motivated, a UCLA supply chain expert explains how to deter such suppliers.

As artificial intelligence technology advances, so do concerns about its misuse. In the lead-up to Florida’s 2024 legislative session, which begins Jan. 9, this is clear from the bills filed over the use of AI-manipulated media.

In today's world, we expect what we need to be available when we need it. That mindset certainly applies to the different medications we're prescribed, which can be debilitating to go without. But now, the U.S. is facing an onslaught of drug shortages, with over 300 drugs in short supply as of late spring—the highest number in a decade. Making matters worse, the average shortage impacts a least half a million people, according to an Office of the Assistant Secretary for Planning and Evaluation (ASPE) report to Congress. And we could see several drug shortages continue in 2024.